Prot# D2782C00007: A Phase I/II, Open-Label, Multi-Center, Two-Part Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of AZD4877 Administered on Days 1,2 and 3 in Adult Patients with Recurrent or Refractory Acute Myelogenous Leukemia

  • Tallman, Martin Stuart (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date3/3/08 → 3/3/11

Funding

  • AstraZeneca Pharmaceuticals LP (D2782C00007)